UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 1 filers reported holding UNIQURE NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,445 | -81.1% | 36,132 | -67.7% | 0.00% | – |
| Q2 2023 | $1,280,656 | -43.8% | 111,750 | -1.2% | 0.00% | -100.0% |
| Q1 2023 | $2,277,793 | -12.1% | 113,098 | -1.1% | 0.00% | 0.0% |
| Q4 2022 | $2,591,386 | +24.3% | 114,309 | +2.9% | 0.00% | 0.0% |
| Q3 2022 | $2,084,000 | +13.4% | 111,108 | +12.7% | 0.00% | 0.0% |
| Q2 2022 | $1,838,000 | +5.1% | 98,572 | +1.9% | 0.00% | 0.0% |
| Q1 2022 | $1,748,000 | -13.6% | 96,716 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $2,022,000 | -33.0% | 97,476 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $3,018,000 | +449.7% | 94,311 | +429.2% | 0.00% | – |
| Q2 2021 | $549,000 | -8.5% | 17,822 | 0.0% | 0.00% | – |
| Q1 2021 | $600,000 | -6.8% | 17,822 | 0.0% | 0.00% | – |
| Q4 2020 | $644,000 | +34.2% | 17,822 | +36.7% | 0.00% | – |
| Q3 2020 | $480,000 | -18.4% | 13,039 | 0.0% | 0.00% | – |
| Q2 2020 | $588,000 | -3.9% | 13,039 | +1.1% | 0.00% | – |
| Q1 2020 | $612,000 | -15.7% | 12,899 | +27.3% | 0.00% | – |
| Q4 2019 | $726,000 | +87.1% | 10,131 | +2.9% | 0.00% | – |
| Q3 2019 | $388,000 | +417.3% | 9,849 | +920.6% | 0.00% | – |
| Q2 2019 | $75,000 | +29.3% | 965 | 0.0% | 0.00% | – |
| Q1 2019 | $58,000 | +107.1% | 965 | 0.0% | 0.00% | – |
| Q4 2018 | $28,000 | +180.0% | 965 | +264.2% | 0.00% | – |
| Q3 2018 | $10,000 | 0.0% | 265 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | -23.1% | 265 | -87.5% | 0.00% | – |
| Q2 2017 | $13,000 | – | 2,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |